Company raises seed round co-led by Maverick Ventures and Yosemite, with participation from Oncology Ventures

PHILADELPHIA, April 3, 2025 /PRNewswire/ — Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, today publicly launched with an $11.5 million seed funding round co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Ventures. The company began operations this year in partnership with a leading payer in the Northeast to provide evidence-based, supportive cancer care to over 2,500 cancer patients.

“Despite the advances in cancer treatment made over the past 50 years, patients still face a fragmented health system that gets in the way of comprehensive, personalized cancer care,” said Dr. Justin Bekelman, CEO and Co-Founder of Daymark Health and renowned oncologist, innovator, and former leader of Penn Medicine’s Center for Cancer Care Innovation at the Abramson Cancer Center. “We are delighted to launch our care platform to patients across the country and set a new standard of cancer care, one that will redefine what’s possible in oncology.”

About two million people are diagnosed with cancer in the United States annually, and each one will spend over 8,500 hours per year outside the four walls of their oncology clinic – meaning patients are often left to manage questions, symptoms, and urgent needs on their own. Daymark Health was founded to address the clinical, mental health, and social needs that matter most to patients with cancer, delivered through a comprehensive, proven cancer care platform and a value-based care model that takes on total cost of care risk contracts for health plans. Through partnerships with payers, Daymark’s community-based team of nurse practitioners, nurses, social workers, and Health Partners works in tandem with a patient’s own oncologists and primary care providers to optimize the delivery of care, both virtually and in the home.

Daymark Health’s $11.5 million financial investment from the industry’s premier healthcare and oncology funds – Maverick Ventures, Yosemite, and Oncology Ventures – will allow the company to expand its clinical team, accelerate the development and scale of its platform, and launch new health plan partnerships across the country.

“Daymark Health represents the next evolution in specialty value-based care companies – optimizing care for the special and complex population of patients with cancer,” said Ambar Bhattacharyya, Managing Director at Maverick Ventures. “We are thrilled to partner with Dr. Bekelman and the team at Daymark to bring this proven care model to fruition.”

“There is a glaring need to reform cancer care delivery to reflect the realities of the patient experience. Daymark’s platform for navigating care does just that — aligning patients, providers, and payers for personalized care and improved outcomes,” said Matt Bettonville, Investor at Yosemite.

Alongside Dr. Bekelman, Daymark has assembled an exceptional team of oncology and value-based care leaders. Roy Beveridge, former Chief Medical Officer of Humana and U.S. Oncology, joins Daymark as Executive Board Chair, and Ezekiel Emanuel, an architect of the Affordable Care Act, joins Daymark as Clinical Advisory Board Chair. Daymark was launched out of Healthcare Foundry as a built-for-purpose company, with Robert Pahlavan and Jonathan Rhodes as co-founders leading thesis development – both of whom have assumed roles within Daymark to support the company’s growth and operations.

To learn more about Daymark’s services, please visit www.daymarkhealth.com.

About Daymark Health
Daymark Health is a cancer care company that partners with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Daymark’s supportive, personalized cancer care program empowers patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home.

Press Contact:
press@daymarkhealth.com

SOURCE Daymark Health

Copyright © 2025 Cision US Inc.